Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 5/20 | 0.49 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.49 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.39 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30116765 | 0.83 | CHRNB2 (0.31) | CHRNB2CHRNA4 | |
| SCHEMBL25861913 | 0.83 | CHRNB2 (0.31) | CHRNB2CHRNA4 | |
| SCHEMBL30116760 | 0.82 | CHRNB2 (0.32) | CHRNB2CHRNA4 | |
| SCHEMBL28973745 | 0.82 | CHRNB2 (0.32) | CHRNB2CHRNA4 | |
| SCHEMBL30116768 | 0.79 | ACACB (0.35) | CHRNA7 | |
| SCHEMBL24154693 | 0.79 | ACACB (0.35) | CHRNA7 | |
| SCHEMBL8487566 | 0.77 | CHRNB2 (0.56) | CHRNB2CHRNA4CHRNA3CHRNA7 | |
| SCHEMBL30116807 | 0.76 | RAB9A (0.44) | CHRNB2CHRNA4CHRNA7 | |
| SCHEMBL25861916 | 0.76 | RAB9A (0.44) | CHRNB2CHRNA4CHRNA7 | |
| SCHEMBL8076992 | 0.75 | CHRNA7 (0.46) | CHRNB2CHRNA4CHRNA3CHRNA7CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230225323-A1 | COMPOSITIONS AND METHODS FOR PARASITE CONTROL | PHILIP MORRIS PRODUCTS S.A. (CH) | 2023-07-20 | — | — | US | disclosed |
| US-20230225323-A1 | COMPOSITIONS AND METHODS FOR PARASITE CONTROL | PHILIP MORRIS PRODUCTS S.A. (CH) | 2023-07-20 | — | — | US | disclosed |
| US-20230225323-A1 | COMPOSITIONS AND METHODS FOR PARASITE CONTROL | PHILIP MORRIS PRODUCTS S.A. (CH) | 2023-07-20 | — | — | US | disclosed |
| EP-4172156-A1 | COMPOSITIONS AND METHODS FOR PARASITE CONTROL | Philip Morris Products S.A. (CH) | 2023-05-03 | — | — | EP | disclosed |
| WO-2021260029-A1 | COMPOSITIONS AND METHODS FOR PARASITE CONTROL | PHILIP MORRIS PRODUCTS S.A. (CH) | 2021-12-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230225323-A1 | COMPOSITIONS AND METHODS FOR PARASITE CONTROL | TRHDE, CUTA, PIGS | CHRNB2 4302/4885CHRNA4 3979/4885CHRNA3 3915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.